Allogeneic gene therapy with BMP-2-transduced mesenchymal stem cells combined with immunosuppression enhances bone healing.
Ball JR., Gallo MC., Wier J., Hernandez F., Shelby T., Elias A.
Animal Study on Immune Modulation, published in Mol Ther (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Mol Ther (2025)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41088754
- DOI
- 10.1016/j.ymthe.2025.10.028
Abstract (original English)
Critical-sized bone defects remain a significant clinical challenge with limited treatment options. This study investigated whether allogeneic adipose-derived stem cells (ADSCs) transduced with a lentiviral vector to express BMP-2 could effectively heal femoral defects in immune competent rats with or without temporary FK506 (i.e., tacrolimus) immunosuppression. Forty-three Lewis rats with 6 mm mid-diaphyseal femoral defects received either BMP-2-transduced or non-transduced allogeneic ADSCs from Sprague-Dawley donors, with or without FK506. At 12 weeks, immunosuppressed rats receiving BMP-2-transduced ADSCs achieved healed bone with significantly higher torsional stiffness, peak torque, and energy to failure compared with those not receiving immunosuppression. Similarly, radiographic healing scores, histology, and micro-CT analysis revealed greater new bone formation in immunosuppressed animals. Non-transduced ADSCs produced minimal bone healing regardless of immunosuppression. FK506 did not enhance in vitro BMP-2 production or osteogenic differentiation, suggesting its primary benefit at the tested dose was immunomodulatory rather than enhancing osteoinductive activity. These findings establish that temporary immunosuppression dramatically enhances the efficacy of allogeneic cell-based gene therapy for bone regeneration without significant complications, potentially enabling
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review
Systematic Review with a reported sample of 609 on Hair Loss, Immune Modulation, Autoimmune Research, published in Dermatol Reports (2026) — summary generated from the PubMed abstract.
- 2026
- n = 609
Dermatol Reports - Level ASystematic ReviewPubMed
Regeneration in Aesthetic Medicine: Mechanisms, Evidence, and Clinical Boundaries.
Systematic Review on Skin Aging, Immune Modulation, published in J Cosmet Dermatol (2026) — summary generated from the PubMed abstract.
- 2026
J Cosmet Dermatol - Level ASystematic ReviewEurope PMC
Molecular and Regenerative Effects of Platelet-Rich Plasma and Related Hemocomponents in Animal Models of Liver Injury-A Systematic Review
Systematic Review on Immune Modulation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level ASystematic ReviewPubMed
Stromal Vascular Fraction in Bone Healing: A Systematic Review of Clinical Evidence and Potential Implications in Skull Base Reconstruction and Cranioplasty.
Systematic Review with a reported sample of 214 on Chronic Wound, Immune Modulation, published in J Craniofac Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 214
J Craniofac Surg - Level AMeta-analysisEurope PMC
The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trials
Meta-analysis on Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol